PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,655 stories, page 320 of 645

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07444619: A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07416526: A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07414836: A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07365319: A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07351019: Colonoscopy Bowel Prep Comparison Among Diabetic Patients

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07286149: A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07279571: GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07227168: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07226843: A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07223593: Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07220642: Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07161999: Study of COYA 302 for the Treatment of ALS

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07159204: Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07114601: A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07101666: Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07042191: A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07024706: Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07023627: A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06783309: CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06747884: Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06716866: Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06705920: Effect of Topical Active Oxygen Therapy on Surgical Site Wound Healing and Microbial Colonization

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06602908: Functional Status for Surgically and Non-surgically Treated Patients With Acute Achilles Tendon Rupture Following a Public Municipal Rehabilitation

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06600568: Novel Therapeutic Approach for Human T-cell Malignancies

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06498713: Patient Controlled Administration of Liquid Acetaminophen

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06338995: A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05874297: Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05553912: QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05401110: Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05107115: Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04221542: Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03277703: Flu Vaccine Response in Patients on Biologic Therapies

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02453282: Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02313571: Breakthrough Pain Computer Integrated Patient Controlled Epidural Analgesia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 Healthcare Stocks Retail Investors Are Watching As Hiring Slows

simplywall.stOriginal source
🇺🇰Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Expert Comment: Climate-friendly food procurement and advertising: what are local authorities in England doing?

Oxford MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Gillibrand, Scott press FDA on shortage of cancer drugs

Sun Community NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA approves Takeda's sleep disorder pill

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg

The Lufkin Daily NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra Food and Drug Administration places one-year ban on analogue, non-dairy paneer

The HinduOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA finalizes antimicrobial animal drug safety guidance

FeedstuffsOriginal source
🇪🇸Researchcnic.esTier 2 · Direct publisher

Jennifer Van Eyk: "Me encantan las proteínas"

CNIC Spain CardiovascularOriginal source
🇪🇸Researchcnic.esTier 2 · Direct publisher

The EMBO Journal: Identifican una proteína esencial para prevenir el daño hepático y el desarrollo de tumores durante el envejecimiento

CNIC Spain CardiovascularOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vir Biotech earnings beat by $0.14, revenue topped estimates

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech-Backed Psoriasis Skincare

Trend HunterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Technology Launches Premium Subscription Service for Industry Data and Analysis

geneonline.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech IPO Fever Shows No Signs of Breaking

Institutional InvestorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Applied Biologics Gains IRB Approval for Phase 3 BIOxHEAL Trial in Diabetic Foot Ulcers

BioPharm InternationalOriginal source
🇺🇸Researchfrazierls.comTier 2 · Direct publisher

Braveheart Bio Announces Pricing of Upsized Initial Public Offering

Frazier Life SciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teaching AI to "Know" All About Drugs, Not Just Their Shape: A New Way to Predict Drug Toxicity

Physicians Committee for Responsible MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Manufacturing deal prepares Rett gene therapy for potential U.S. launch

Rett Syndrome NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Innovation1 Biotech Inc. – OTC:IVBT

TradingViewOriginal source
🇺🇸Researchorbimed.comTier 2 · Direct publisher

Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease

OrbiMedOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Who Is Steven Quay, the Biotech Exec Likely to Take Fauci's Old Job?

medpagetoday.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech, Inc. (MBRX) CFO buys 293,333 shares and 879,999 warrants

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech (MBRX) CSO buys common stock and Series I Warrants

Stock TitanOriginal source
🌍Mediaskpharmteco.comTier 3 · Secondary coverage

Global GLP-1 Peptide Development Across The US, EU, and Asia

SkpharmtecoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lotte Holdings invests in Metaphore, 10th HB-CVC biotech deal

International Business TimesOriginal source
🇺🇸CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Emergent BioSolutionsOriginal source